NCT05438069
German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany
Jena University Hospital·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Hypercholesterolemia
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Jena University Hospital
- Location
- Jena, Germany
Timeline & enrollment
- Phase
- N/A
- Start date
- Dec 11, 2020
- End date
- Dec 11, 2025
- Enrollment
- 500 participants
Primary outcome
LDL-C change
Summary
The German Inclisiran Network is a registry of patients with hypercholesterinemia on
 treatment with the siRNA inclisiran in Germany
ICD-10 classifications
Pure hypercholesterolaemiaLipoprotein deficiencyHyperglycaemia, unspecifiedDisorders of lipoprotein metabolism and other lipidaemiasOther disorders of lipoprotein metabolism
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05438069
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT05438069 through Pure Global AI's free database. This phase not specified trial is sponsored by Jena University Hospital and is currently Recruiting. The study focuses on Hypercholesterolemia. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.